Last updated: February 27, 2024
Sponsor: Andreas Guenther
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Cystic Fibrosis
Pulmonary Fibrosis
Scar Tissue
Treatment
patient registry (observation and biomaterial sampling)
Clinical Study ID
NCT02951416
EurIPFreg_150609
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Informed consent signed
Exclusion
Exclusion Criteria:
- No informed consent signed
Study Design
Total Participants: 2000
Treatment Group(s): 1
Primary Treatment: patient registry (observation and biomaterial sampling)
Phase:
Study Start date:
September 01, 2009
Estimated Completion Date:
January 31, 2040
Study Description
Connect with a study center
Medizinische Universität Wien
Vienna,
AustriaSite Not Available
Centre Hospitalier Universitaire Dijon
Dijon,
FranceSite Not Available
Hopital Bichat Paris
Paris,
FranceSite Not Available
Lungenfachklinik Waldhof Elgershausen
Elgershausen. Greifenstein,
GermanySite Not Available
Andreas Guenther
Giessen, 35392
GermanySite Not Available
Lungenfachklinik Waldhof Elgershausen
Greifenstein,
GermanySite Not Available
Università degli Studi di Catania
Catania,
ItalySite Not Available
Royal Brompton Hospital
London,
United KingdomSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.